Home » Reports » Broker Ratings » GlaxoSmithKline plc 32.1% Potential Upside Indicated by Berenberg
broker ratings

GlaxoSmithKline plc 32.1% Potential Upside Indicated by Berenberg

GlaxoSmithKline plc using EPIC/TICKER code (LON:GSK) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at Berenberg. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. Berenberg have set their target price at 1705 GBX on its stock. This would imply the analyst believes there is now a potential upside of 32.1% from today’s opening price of 1290.6 GBX. Over the last 30 and 90 trading days the company share price has decreased 40.4 points and decreased 31.9 points respectively. The 52 week high share price is 1724.5 GBX while the 52 week low is 1235.2 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,330.94 GBX and the 200 Day Moving Average price is recorded at 1,491.21. There are currently 4,957,947,538 shares in issue with the average daily volume traded being 9,218,959. Market capitalisation for LON:GSK is £64,066,595,665 GBP.

You might also find these articles of interest:

Register here to be notified of future articles like this
Get all our broker ratings on Twitter as they are published!